1. Home
  2. ICLR vs ARE Comparison

ICLR vs ARE Comparison

Compare ICLR & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICLR
  • ARE
  • Stock Information
  • Founded
  • ICLR 1990
  • ARE 1994
  • Country
  • ICLR Ireland
  • ARE United States
  • Employees
  • ICLR N/A
  • ARE N/A
  • Industry
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • ARE Real Estate Investment Trusts
  • Sector
  • ICLR Health Care
  • ARE Real Estate
  • Exchange
  • ICLR Nasdaq
  • ARE Nasdaq
  • Market Cap
  • ICLR 14.3B
  • ARE 13.2B
  • IPO Year
  • ICLR 1998
  • ARE 1997
  • Fundamental
  • Price
  • ICLR $157.88
  • ARE $55.34
  • Analyst Decision
  • ICLR Buy
  • ARE Hold
  • Analyst Count
  • ICLR 15
  • ARE 10
  • Target Price
  • ICLR $211.36
  • ARE $93.00
  • AVG Volume (30 Days)
  • ICLR 989.2K
  • ARE 3.1M
  • Earning Date
  • ICLR 10-22-2025
  • ARE 10-27-2025
  • Dividend Yield
  • ICLR N/A
  • ARE 9.49%
  • EPS Growth
  • ICLR N/A
  • ARE N/A
  • EPS
  • ICLR 7.47
  • ARE N/A
  • Revenue
  • ICLR $8,102,602,000.00
  • ARE $3,058,395,000.00
  • Revenue This Year
  • ICLR N/A
  • ARE N/A
  • Revenue Next Year
  • ICLR $0.89
  • ARE N/A
  • P/E Ratio
  • ICLR $21.41
  • ARE N/A
  • Revenue Growth
  • ICLR N/A
  • ARE N/A
  • 52 Week Low
  • ICLR $125.10
  • ARE $52.94
  • 52 Week High
  • ICLR $228.29
  • ARE $114.69
  • Technical
  • Relative Strength Index (RSI)
  • ICLR 33.43
  • ARE 25.23
  • Support Level
  • ICLR $159.19
  • ARE $52.94
  • Resistance Level
  • ICLR $167.87
  • ARE $58.70
  • Average True Range (ATR)
  • ICLR 8.45
  • ARE 2.65
  • MACD
  • ICLR -2.75
  • ARE -1.43
  • Stochastic Oscillator
  • ICLR 4.93
  • ARE 9.56

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Share on Social Networks: